CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Raises Price Target on Ultragenyx Pharmaceutical to $30 From $26, Keeps Neutral Rating

Positive
AI Analysis

Summary

Wedbush raised its price target on Ultragenyx Pharmaceutical to $30 from $26 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.30
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 11:38 AM

Read Original